Ventas (VTR) Tops Q2 EPS by 1c; offers guidance
Tweet
Share
E-mail
Get Alerts VTR Hot Sheet
Price: $87.03 --0%
EPS Growth %: +14.3%
Financial Fact:
Medical office building services costs: 974K
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +14.3%
Financial Fact:
Medical office building services costs: 974K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Ventas (NYSE: VTR) reported Q2 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.37 billion.
GUIDANCE:
Ventas sees FY2025 EPS of $0.47-$0.52, versus the consensus of $0.41.
For earnings history and earnings-related data on Ventas (VTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Envoy Medical receives two new patents, expanding portfolio to 97
- Polyrizon enrolls first patient in U.S. allergy blocker study
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
